Abstract
This paper documented several natural products that have antineoplastic activities. Detailed descriptions of the mechanism of action of these products are given. Side effects of these natural products are also described. Based on these side effect profiles and their benefits, these natural products could be used as adjuvant cancer therapies. Traditional anticancer agents usually have debilitating side effects. These natural products would be of great benefit due to their anticancer activities. Additionally, some of these natural products can work proactively in preventing cancer formation with their chemopreventive properties. Incorporation into diet can be recommended after discussion with physician and other health care professionals.
Similar content being viewed by others
Abbreviations
- ACAT:
-
A-cholesterol acyltransferase
- AE-BS:
-
B. scorzonerifolium extracted with acetone
- CDDP:
-
cis-diamminedichloroplatinum(II)
- CDK:
-
Cyclin-dependent kinase
- CLU:
-
Clusterin
- CYP:
-
Cytochrome P450
- dD AVP:
-
Vasopressin derivative
- EC:
-
(-)-Epicatechin
- ECCs:
-
Esophageal cancer cells
- ECG:
-
(-)-Epicatechin-3-gallate
- EGC:
-
(-)-Epigallocatechin
- EGCG:
-
(-)-Epigallocatechin-3-gallate
- GADD153:
-
Growth arrest and DNA damage-inducible gene 153
- IGF-1:
-
Insulin-like growth factor I
- LLC:
-
Lewis lung carcinoma
- MAPK:
-
Mitogen-activated protein kinase
- NF-kappaB:
-
Nuclear factor kappa B
- NK:
-
Natural killer
- PCWE:
-
Polygonum cuspidatum water extract
- Rh2:
-
Ginsenoside Rh2
- TPA:
-
12-O-Tetradecanoyl phorbol-13-acetate
- VEGF:
-
Vascular endothelial growth factor
- XIAP:
-
X-linked inhibitor of apoptosis
References
Stiborova M, Breuer A, Aimova D, Stiborova-Rupertova M, Wiessler M, Frei E. DNA adduct formation by the anticancer drug ellipticine in rats determined by 32P postlabeling. Int J Cancer. 2003;107:885–90.
Siu D. Activity-dependent hepatocyte growth factor expression and its role in organogenesis and cancer growth suppression. Med Hypotheses. 2004;63:62–70.
Iizuka N, Miyamoto K, Okita K, Tangoku A, Hayashi H, Yosino S, Abe T, Morioka T, Hazama S, Oka M. Inhibitory effect of Coptidis Rhizoma and berberine on the proliferation of human esophageal cancer cell lines. Cancer Lett. 2000;148:19–25.
Mitani N, Murakami K, Yamaura T, Ikeda T, Saiki I. Inhibitory effect of berberine on the mediastinal lymph node metastasis produced by orthotopic implantation of Lewis lung carcinoma. Cancer Lett. 2001;165:35–42.
Kim YJ, Kang SA, Hong MS, Park HJ, Kim MJ, Park HJ, Kim HK. Coptidis rhizoma induces apoptosis in human colorectal cancer cells SNU-C4. Am J Chin Med. 2004;32:873–82.
Iizuka N, Miyamoto K, Okita K, Tangoku A, Hayashi H, Yosino S, Abe T, Morioka T, Hazama S, Oka M. Inhibitory effect of Coptidis Rhizoma and berberine on the proliferation of human esophageal cancer cell lines. Cancer Lett. 2000;148:19–25.
Chen JK, Chen TT. Chinese medical herbology and pharmacology. 2nd ed. California: Art of Medicine Press; 2004.
Park CS, Lee YC, Kim JD, Kim HM, Kim CH. Inhibitory effects of Polygonum cuspidatum water extract (PCWE) and its component resveratrol [correction of rasveratrol] on acyl-coenzyme A-cholesterol acyltransferase activity for cholesteryl ester synthesis in HepG2 cells. Vascul Pharmacol. 2004;40:279–84.
Fuggetta MP, D’Atri S, Lanzilli G, Tricarico M, Cannavo E, Zambruno G, Falchetti R, Ravagnan G. In vitro antitumour activity of resveratrol in human melanoma cells sensitive or resistant to temozolomide. Melanoma Res. 2004;14:189–96.
Kimura Y, Okuda H. Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice. J Nutr. 2001;131:1844–9.
Feng L, Zhang LF, Yan T, Jin J, Tao WY. Studies on active substance of anticancer effect in Polygonum cuspidatum. Zhong Yao Cai. 2006;29:689–91.
Giridharan P, Somasundaram ST, Perumal K, Vishwakarma RA, Karthikeyan NP, Velmurugan R, Balakrishnan A. Novel substituted methylenedioxy lignan suppresses proliferation of cancer cells by inhibiting telomerase and activation of c-myc and caspases leading to apoptosis. Br J Cancer. 2002;87:98–105.
Huang ST, Yang RC, Chen MY, Pang JH. Phyllanthus urinaria induces the Fas receptor/ligand expression and ceramide-mediated apoptosis in HL-60 cells. Life Sci. 2004;75:339–51.
Huang ST, Yang RC, Yang LJ, Lee PN, Pang JH. Phyllanthus urinaria triggers the apoptosis and Bcl-2 down-regulation in Lewis lung carcinoma cells. Life Sci. 2003;72:1705–16.
Kiefer D, Pantuso T. Panax ginseng. Am Fam Physician. 2003;68:1539–42.
Chang YS, Seo EK, Gyllenhaal C, Block KI. Panax ginseng: a role in cancer therapy? Integr Cancer Ther. 2003;2:13–33.
Nakata H, Kikuchi Y, Tode T, Hirata J, Kita T, Ishii K, Kudoh K, Nagata I, Shinomiya N. Inhibitory effects of ginsenoside Rh2 on tumor growth in nude mice bearing human ovarian cancer cells. Jpn J Cancer Res. 1998;89:733–40.
Sagar SM, Yance D, Wong RK. Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer-Part 1. Curr Oncol. 2006;13:14–26.
Cheng YL, Chang WL, Lee SC, Liu YG, Lin HC, Chen CJ, Yen CY, Yu DS, Lin SZ, Harn HJ. Acetone extract of Bupleurum scorzonerifolium inhibits proliferation of A549 human lung cancer cells via inducing apoptosis and suppressing telomerase activity. Life Sci. 2003;73:2383–94.
Cheng YL, Lee SC, Lin SZ, Chang WL, Chen YL, Tsai NM, Liu YC, Tzao C, Yu DS, Harn HJ. Anti-proliferative activity of Bupleurum scrozonerifolium in A549 human lung cancer cells in vitro and in vivo. Cancer Lett. 2005;222:183–93.
Hsia SM, Yeh CL, Kuo YH, Wang PS, Chiang W. Effects of adlay (Coix lachryma-jobi L. var. ma-yuen Stapf.) hull extracts on the secretion of progesterone and estradiol in vivo and in vitro. Exp Biol Med (Maywood). 2007;232:1181–94.
Chang HC, Huang YC, Hung WC. Antiproliferative and chemopreventive effects of adlay seed on lung cancer in vitro and in vivo. J Agric Food Chem. 2003;51:3656–60.
Hung WC, Chang HC. Methanolic extract of adlay seed suppresses COX-2 expression of human lung cancer cells via inhibition of gene transcription. J Agric Food Chem. 2003;51:7333–7.
Wu J, Wu Y, Yang BB. Anticancer activity of Hemsleya amabilis extract. Life Sci. 2002;71:2161–70.
Garbett NC, Graves DE. Extending nature’s leads: the anticancer agent ellipticine. Curr Med Chem Anti-Canc Agents. 2004;4:149–72.
Stiborova M, Rupertova M, Schmeiser HH, Frei E. Molecular mechanisms of antineoplastic action of an anticancer drug ellipticine. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2006;150:13–23.
Stiborova M, Stiborova-Rupertova M, Borek-Dohalska L, Wiessler M, Frei E. Rat microsomes activating the anticancer drug ellipticine to species covalently binding to deoxyguanosine in DNA are a suitable model mimicking ellipticine bioactivation in humans. Chem Res Toxicol. 2003;16:38–47.
Faddeeva MD, Beliaeva TN. Sanguinarine and ellipticine cytotoxic alkaloids isolated from well-known antitumor plants. Intracellular targets of their action]. Tsitologiia. 1997;39:181–208.
Frei E, Bieler CA, Arlt VM, Wiessler M, Stiborova M. Covalent binding of the anticancer drug ellipticine to DNA in V79 cells transfected with human cytochrome P450 enzymes. Biochem Pharmacol. 2002;64:289–95.
Chitra M, Sukumar E, Suja V, Devi CS. Antitumor, anti-inflammatory and analgesic property of embelin, a plant product. Chemotherapy. 1994;40:109–13.
Nikolovska-Coleska Z, Xu L, Hu Z, Tomita Y, Li P, Roller PP, Wang R, Fang X, Guo R, Zhang M, Lippman ME, Yang D, Wang S. Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database. J Med Chem. 2004;47:2430–40.
Mori T, Doi R, Kida A, Nagai K, Kami K, Ito D, Toyoda E, Kawaguchi Y, Uemoto S. Effect of the XIAP inhibitor Embelin on TRAIL-induced apoptosis of pancreatic cancer cells. J Surg Res. 2007;142:281–6.
Scott DW, Loo G. Curcumin-induced GADD153 gene upregulation in human colon cancer cells. Carcinogenesis. 2004;25:2155–64.
Radhakrishna Pillai G, Srivastava AS, Hassanein TI, Chauhan DP, Carrier E. Induction of apoptosis in human lung cancer cells by curcumin. Cancer Lett. 2004;208:163–70.
Blasiak J, Trzeciak A, Kowalik J. Curcumin damages DNA in human gastric mucosa cells and lymphocytes. J Environ Pathol Toxicol Oncol. 1999;18:271–6.
Chauhan DP. Chemotherapeutic potential of curcumin for colorectal cancer. Curr Pharm Des. 2002;8:1695–706.
Collett GP, Campbell FC. Curcumin induces c-jun N-terminal kinase-dependent apoptosis in HCT116 human colon cancer cells. Carcinogenesis. 2004;25:2183–9.
Thangapazham RL, Sharma A, Maheshwari RK. Multiple molecular targets in cancer chemoprevention by curcumin. AAPS J. 2006;8:E443–9.
Kakar SS, Roy D. Curcumin inhibits TPA induced expression of c-fos, c-jun and c-myc proto-oncogenes messenger RNAs in mouse skin. Cancer Lett. 1994;87:85.
Koo JY, Kim HJ, Jung KO, Park KY. Curcumin inhibits the growth of AGS human gastric carcinoma cells in vitro and shows synergism with 5-fluorouracil. J Med Food. 2004;7:117–21.
Van’t Land B, Blijlevens NM, Marteijn J, Timal S, Donnelly JP, de Witte TJ, M’Rabet L. Role of curcumin and the inhibition of NF-kappaB in the onset of chemotherapy-induced mucosal barrier injury. Leukemia. 2004;18:276–84.
Acknowledgments
I sincerely wrote this article in memory of Dr. Neil Towers, who passed away in the morning of November 15, 2004. This is to hope that Dr. Neil Towers’s work ethics, goals, and dreams live on by me. Dr. Neil Towers was a Pergamon Phytochemistry Prize recipient.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Siu, D. Natural products and their role in cancer therapy. Med Oncol 28, 888–900 (2011). https://doi.org/10.1007/s12032-010-9528-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12032-010-9528-x